John Kauh will present a poster at the CHEST 2024 Annual Meeting – AIM-HI Accelerator Fund
AIM-HI Accelerator Fund recently shared about John Kauh presenting a poster at the CHEST 2024 Annual Meeting. Read the post on LinkedIn below:
“Exciting Update!
AIM-HI portfolio company, Tvardi Therapeutics, a privately held, clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, announced that John Kauh, M.D., Chief Medical Officer, will present a poster at the American College of Chest Physicians (CHEST) 2024 Annual Meeting, which is being held October 6-9, in Boston, Massachusetts.
John Kauh is the Chief Medical Officer at Tvardi Therapeutics and a board-certified medical oncologist with experience in drug development and regulatory submissions in the U.S. and EU. Previously, he was Vice President of Clinical Development at HUTCHMED, overseeing clinical trials from Phase 1 to Phase 3.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023